$KNSA 8-K SEC Filings

Filed On	Filing
27 Oct 2026	8-K: Results of Operations and Financial Condition Date of Report (Date of earliest event reported): October 27, 2026
22 Oct 2026	8-K: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers On October 17, 2026, the Compensation Committee (the “Committee”) of the Board of Directors of Kiniksa Pharmaceuticals International, plc (the “Company”) appointed Ross Moat as President and Chief Operating Officer, effective immediately...
28 Jul 2026	8-K: Results of Operations and Financial Condition
29 May 2026	8-K: Submission of Matters to a Vote of Security Holders
26 May 2026	8-K: Entry into a Material Definitive Agreement
01 May 2026	8-K: Departure/Election of Directors or Officers; Compensation
28 Apr 2026	8-K: Results of Operations and Financial Condition
24 Feb 2026	8-K: Results of Operations and Financial Condition
14 Jan 2026	8-K: Departure/Election of Directors or Officers; Compensation
12 Jan 2026	8-K: Results of Operations and Financial Condition
28 Oct 2025	8-K: Results of Operations and Financial Condition
03 Sep 2025	8-K: Regulation FD Disclosure
29 Jul 2025	8-K: Results of Operations and Financial Condition
05 Jun 2025	8-K: Regulation FD Disclosure
03 Jun 2025	8-K: Submission of Matters to a Vote of Security Holders
29 Apr 2025	8-K: Results of Operations and Financial Condition
23 Apr 2025	8-K: Departure/Election of Directors or Officers; Compensation
25 Feb 2025	8-K: Termination of a Material Definitive Agreement; Results of Operations and Financial Condition +1 more
13 Jan 2025	8-K: Results of Operations and Financial Condition
29 Oct 2024	8-K: Results of Operations and Financial Condition

Comments